These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 16626510
21. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease. Yang ZJ, Xu SL, Chen B, Zhang SL, Zhang YL, Wei W, Ma DC, Wang LS, Zhu TB, Li CJ, Wang H, Cao KJ, Gao W, Huang J, Ma WZ, Wu ZZ. Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):790-6. PubMed ID: 19215239 [Abstract] [Full Text] [Related]
23. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs. Li SR, Qi XY, Hu FL, Zhang JQ, Wang TH, Dang Y, Meng CL, Liu HL, Li YX, Wu D, Dong J, Xun LY, Gao LH, Jin FC. Chin Med J (Engl); 2008 Dec 05; 121(23):2403-9. PubMed ID: 19102957 [Abstract] [Full Text] [Related]
24. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis. Lu F, Zhao X, Wu J, Cui Y, Mao Y, Chen K, Yuan Y, Gong D, Xu Z, Huang S. Int J Cardiol; 2013 Sep 10; 167(6):2524-32. PubMed ID: 22981278 [Abstract] [Full Text] [Related]
25. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. Wang Y, Ahmad N, Wani MA, Ashraf M. J Mol Cell Cardiol; 2004 Nov 10; 37(5):1041-52. PubMed ID: 15522281 [Abstract] [Full Text] [Related]
26. Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model. Hao X, Månsson-Broberg A, Grinnemo KH, Siddiqui AJ, Dellgren G, Brodin LA, Sylvén C. Cardiovasc Res; 2007 Feb 01; 73(3):481-7. PubMed ID: 17134685 [Abstract] [Full Text] [Related]
27. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. Chen XH, Minatoguchi S, Kosai K, Yuge K, Takahashi T, Arai M, Wang N, Misao Y, Lu C, Onogi H, Kobayashi H, Yasuda S, Ezaki M, Ushikoshi H, Takemura G, Fujiwara T, Fujiwara H. J Card Fail; 2007 Dec 01; 13(10):874-83. PubMed ID: 18068622 [Abstract] [Full Text] [Related]
28. Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model. Cho KR, Choi JS, Hahn W, Kim DS, Park JS, Lee DS, Kim KB. Eur J Cardiothorac Surg; 2008 Oct 01; 34(4):857-63. PubMed ID: 18620865 [Abstract] [Full Text] [Related]
29. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function. Jayasankar V, Bish LT, Pirolli TJ, Berry MF, Burdick J, Woo YJ. Ann Thorac Surg; 2004 Jun 01; 77(6):2122-9; discussion 2129. PubMed ID: 15172279 [Abstract] [Full Text] [Related]
30. Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction. Jin H, Yang R, Li W, Ogasawara AK, Schwall R, Eberhard DA, Zheng Z, Kahn D, Paoni NF. J Pharmacol Exp Ther; 2003 Feb 01; 304(2):654-60. PubMed ID: 12538818 [Abstract] [Full Text] [Related]
31. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis. Chen LL, Yin H, Huang J. Cardiovasc Pathol; 2007 Feb 01; 16(4):221-30. PubMed ID: 17637430 [Abstract] [Full Text] [Related]
33. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Azuma J, Taniyama Y, Takeya Y, Iekushi K, Aoki M, Dosaka N, Matsumoto K, Nakamura T, Ogihara T, Morishita R. Gene Ther; 2006 Aug 15; 13(16):1206-13. PubMed ID: 16625244 [Abstract] [Full Text] [Related]
34. In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung. Ono M, Sawa Y, Matsumoto K, Nakamura T, Kaneda Y, Matsuda H. Circulation; 2002 Sep 24; 106(12 Suppl 1):I264-9. PubMed ID: 12354744 [Abstract] [Full Text] [Related]
37. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, Zhang G, Suntharalingam P, Boozer S, Mhashilkar A, Panetta CJ, Swingen C, Deans R, From AH, Bache RJ, Verfaillie CM, Zhang J. Circulation; 2007 Apr 10; 115(14):1866-75. PubMed ID: 17389266 [Abstract] [Full Text] [Related]
38. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey LS, Martin BJ, Quyyumi AA, Few WL, Kin H, Guyton RA, Vinten-Johansen J. Basic Res Cardiol; 2008 Nov 10; 103(6):525-36. PubMed ID: 18704259 [Abstract] [Full Text] [Related]
39. Effect of human hepatocyte growth factor on promoting wound healing and preventing scar formation by adenovirus-mediated gene transfer. Ha X, Li Y, Lao M, Yuan B, Wu CT. Chin Med J (Engl); 2003 Jul 10; 116(7):1029-33. PubMed ID: 12890377 [Abstract] [Full Text] [Related]
40. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. Qian HY, Yang YJ, Huang J, Gao RL, Dou KF, Yang GS, Li JJ, Shen R, He ZX, Lu MJ, Zhao SH. Chin Med J (Engl); 2007 Aug 20; 120(16):1416-25. PubMed ID: 17825171 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]